News centre | United Kingdom

Philips expands patient monitoring portfolio with additional measurement technologies

April 20, 2016

Amsterdam, the Netherlands – As part of the company’s focus on the development of advanced monitoring solutions, Royal Philips (NYSE: PHG; AEX: PHIA) today announced the launch of its IntelliVue patient monitoring platform with Masimo rainbow® SET technology. Philips also offers its customers the option to add rainbow® SET to existing IntelliVue monitors, and the company is working to integrate the technology into its Philips SureSigns and Philips Efficia patient monitoring platforms.


In conjunction with the appropriate Philips patient monitoring platform, Masimo rainbow® SET technology analyzes multiple wavelengths of light to accurately measure total hemoglobin (SpHb™), oxygen content (SpOC®), carboxyhemoglobin (SpCO™), methemoglobin (SpMet®) and Pleth Variability Index (PVI®) noninvasively and continuously. Continuous monitoring of rainbow SpHb™ on a Philips monitor at the point-of-care provides clinicians with real-time visibility to changes in hemoglobin in between invasive blood sampling.

To ensure that customers have choice of SpO2 pulse oximetry measurement technology, Philips continues to offer Philips FAST SpO2 pulse oximetry and Covidien’s OxiMax SpO2 pulse oximetry, depending on the patient monitoring platform. 

Philips offers a comprehensive portfolio of patient monitoring solutions ranging from bedside monitors to wearable patient monitors, combined with clinical decision support tools and mobile applications to provide immediate access to centrally held patient data. More than 275 million patients were monitored with Philips’ patient monitors in 2014.

For further information, please contact:

Steve Klink

Philips Group Communications

Tel.: +31 6 10888824


About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. News about Philips can be found at

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.